tradingkey.logo
tradingkey.logo

GSK Says Bepirovirsen Accepted For Review By EMA

ReutersMar 27, 2026 7:17 AM

- GSK plc GSK.L:

  • BEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMA

  • EMA ACCEPTS BEPIROVIRSEN FOR REVIEW AS POTENTIAL FIRST-IN-CLASS CHRONIC HEPATITIS B TREATMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI